Get the Stockscreener App
1.08
2.86%
0.03
After Hours:
1.10
0.02
+1.85%
Biofrontera Inc stock is traded at $1.08, with a volume of 118.72K.
It is up +2.86% in the last 24 hours and up +51.79% over the past month.
Biofrontera Inc is a United States-based biopharmaceutical company commercializing a portfolio of pharmaceutical products for the treatment of dermatological conditions with a focus on photodynamic therapy. The Company's licensed products, which include Ameluz as well as the BF-RhodoLED and RhodoLED XL lamps (together, the RhodoLED Lamps), are used for the treatment of actinic keratoses (AKs), which are pre-cancerous skin lesions.
See More
Previous Close:
$1.05
Open:
$1.04
24h Volume:
118.72K
Relative Volume:
0.64
Market Cap:
$14.69M
Revenue:
$34.07M
Net Income/Loss:
$-20.13M
P/E Ratio:
-0.0836
EPS:
-12.92
Net Cash Flow:
$-24.90M
1W Performance:
-2.26%
1M Performance:
+51.79%
6M Performance:
-4.42%
1Y Performance:
-9.99%
1-Day Range:
$1.035
$1.14
1-Week Range:
$0.99
$1.14
52-Week Range:
$0.536
$2.22
Biofrontera Inc Stock (BFRI) Company Profile
Name
Biofrontera Inc
Sector
Phone
781-245-1325
Address
120 PRESIDENTIAL WAY,, WOBURN
Compare BFRI with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
BFRI
Biofrontera Inc
|
1.08 | 10.65M | 34.07M | -20.13M | -24.90M | -12.92 |
|
ZTS
Zoetis Inc
|
145.79 | 66.25B | 9.29B | 2.52B | 2.28B | 5.57 |
|
TAK
Takeda Pharmaceutical Co Adr
|
13.72 | 42.95B | 30.08B | 710.16M | 4.45B | 0.2182 |
|
HLN
Haleon Plc Adr
|
9.43 | 43.30B | 14.35B | 1.85B | 0 | 0.4023 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
15.45 | 19.30B | 16.54B | -1.64B | 749.00M | -1.45 |
|
NBIX
Neurocrine Biosciences Inc
|
128.23 | 13.53B | 2.41B | 305.80M | 492.20M | 2.95 |
Biofrontera Inc Stock (BFRI) Latest News
Is Biofrontera Inc. a growth stock or a value stockStock Strategy Entry Points Backed By Experts - jammulinksnews.com
Why Biofrontera Inc. stock attracts strong analyst attentionHigh Conviction Intraday Stock Signals Detected - metal.it
Fibonacci Retracement Aligns with Support in Biofrontera Inc. Equity WarrantSmart Trade Plans With Risk Protection Explained - metal.it
Moving Average Crossover Confirms Uptrend in Biofrontera Inc.Fast Gaining Stock Screener Reports Released - metal.it
How institutional ownership impacts Biofrontera Inc. Equity Warrant stock7-Day Equity Return Range Forecast Model - Newser
Why Biofrontera Inc. Equity Warrant stock attracts strong analyst attentionStep-by-Step Trade Signal Implementation Guide Ready - metal.it
How does Biofrontera Inc. generate profit in a changing economyFinancial News Data Feed With High Returns - jammulinksnews.com
What catalysts could drive Biofrontera Inc. stock higher in 2025Invest smarter with high-probability setups - jammulinksnews.com
What are the technical indicators suggesting about Biofrontera Inc. Equity WarrantSuperior portfolio returns - jammulinksnews.com
What institutional investors are buying Biofrontera Inc. stockAchieve rapid portfolio growth with expert guidance - jammulinksnews.com
Has Biofrontera Inc. formed a bullish divergenceFree Target Return Focused Trade Insights - Newser
How Biofrontera Inc. Equity Warrant stock performs during market volatilityShort-Term Swing Opportunity Summary Sheet - Newser
What makes Biofrontera Inc. stock price move sharplyBollinger Band Squeeze and Expansion Analysis - Newser
What is Biofrontera Inc. company’s growth strategyBreakout Stocks Tips For Beginners - jammulinksnews.com
Will Biofrontera Inc. Equity Warrant see short term momentumStrategy Chart for Real-Time Trade Flow - Newser
Using data models to predict Biofrontera Inc. Equity Warrant stock movement Free Daily Momentum Screener With Alerts - Newser
Will Biofrontera Inc. Equity Warrant stock recover after recent drop Free Daily Picks With Predictable Performance - Newser
What are analysts’ price targets for Biofrontera Inc. Equity Warrant in the next 12 monthsAccelerated profit realization - jammulinksnews.com
Why is Biofrontera Inc. Equity Warrant stock attracting strong analyst attentionSky-high return potential - jammulinksnews.com
How strong is Biofrontera Inc. Equity Warrant company’s balance sheetCapitalize on emerging investment opportunities - jammulinksnews.com
How volatile is Biofrontera Inc. Equity Warrant stock compared to the marketUnlock your portfolio’s hidden potential - jammulinksnews.com
When is Biofrontera Inc. stock expected to show significant growthFree Investment Timing Strategies - jammulinksnews.com
What are analysts’ price targets for Biofrontera Inc. in the next 12 monthsMaximize gains with proven stock analysis - jammulinksnews.com
Is Biofrontera Inc. Equity Warrant a growth stock or a value stockInvest confidently with actionable market data - jammulinksnews.com
What is the dividend policy of Biofrontera Inc. Equity Warrant stockExceptional growth trajectory - jammulinksnews.com
Should I hold or sell Biofrontera Inc. stock in 2025Invest confidently with proven investment plans - jammulinksnews.com
Does Biofrontera Inc. stock perform well during market downturnsCapitalize on momentum-driven investment opportunities - jammulinksnews.com
What catalysts could drive Biofrontera Inc. Equity Warrant stock higher in 2025Maximize gains with expert analysis - jammulinksnews.com
Should I hold or sell Biofrontera Inc. Equity Warrant stock in 2025Rapid capital growth - jammulinksnews.com
Published on: 2025-07-28 01:21:39 - jammulinksnews.com
How does Biofrontera Inc. Equity Warrant compare to its industry peersBuild a diversified portfolio for steady growth - jammulinksnews.com
How Efficient Is Biofrontera Inc. at Controlling Operating CostsHigh Return Intraday Picks - Newser
What makes Biofrontera Inc. Equity Warrant stock price move sharplyDouble Profit With Half Risk - Newser
Biofrontera Inc Stock (BFRI) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.90%
0.85%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):